SAFIRE: AI predicted ADME for drug discovery: leveraging BioPrint
Join Dr Carleton Sage to learn about predicting ADME properties as a key approach to improving the efficiency of small molecule drug discovery. AI ADME model development approaches and case studies within drug discovery projects will be discussed.
New targeted therapies show promise in lung cancer treatment
By Dr Eleni Lagkadinou (Vice President of Oncology Early Development…
Differentiated therapies: Unlocking stem cell medicine with epigenetics
By Cameron Lee (Tune Therapeutics)
Toxicology transformed: Why accuracy now leads the way
By Bhupesh D. Sompura – Method Development Team Lead at…
AI paves the way for new immunotherapy targets
By Michelle Teng - CEO of Etcembly
Beyond the lab: neuroscience
Download this free report to explore the future of neuroscience and current developments in drug discovery. It features interviews with experts discussing challenges and historical influences in the field, the role of neuroscientists in addressing environmental issues, and personal journeys in neuroscience.
New targeted therapies show promise in lung cancer treatment
By Dr Eleni Lagkadinou (Vice President of Oncology Early Development…
Toxicology transformed: Why accuracy now leads the way
By Bhupesh D. Sompura – Method Development Team Lead at…
Women in STEM with Stella Vnook
By Dr Stella Vnook (Likarda Biotech & OralBiolife Biosciences)